Increased vulnerability of the donor organ in related kidney transplants for certain diseases.
The one-year kidney transplant survival rates from parental donors into recipients with pyelonephritis (PN) was 79% as compared with the low rate of 62% for polycystic disease (PC) and diabetes mellitus (DM). Even more striking was the 42% one-year graft survival in systemic lupus erythematosus (SLE) patients receiving parental donor grafts. HLA-identical sibling donor transplants into patients with DM had a low survival rate of 75% as compared with 90% in PN patients. These results were analyzed for interactions of donor type and disease by comparing the relative survival rates among types of donors within each recipient disease. After taking into account higher overall risks attributable to medical complications inherent in the different disease categories, related donor grafts into patients with PC, SLE, and DM have lower graft survival rates than would be expected from differences in cadaver donor rates by disease. In practical terms, for related donor transplants into patients with SLE, DM, and PC, it may be necessary to consider the vulnerability of the donor organ as another factor.
D002102:Cadaver; D003920:Diabetes Mellitus / Q000276:immunology; D004198:Disease Susceptibility; D005921:Glomerulonephritis / Q000276:immunology; D006085:Graft Survival; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D016030:Kidney Transplantation; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D007690:Polycystic Kidney Diseases / Q000276:immunology; D011704:Pyelonephritis / Q000276:immunology; D012306:Risk; D014019:Tissue Donors
D006680:HLA Antigens